Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System Post author:Sam Post published:March 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Former Biogen Exec Launches First Life Sciences Fund With $750 Million May 22, 2017 Biocon's Biosimilar Arm May Raise $500M to Fund Clinical Development December 21, 2017 Addex Therapeutics Shareholders Approved All Board Proposals At 2017 Annual General Meeting June 22, 2017
Addex Therapeutics Shareholders Approved All Board Proposals At 2017 Annual General Meeting June 22, 2017